Achieve Life Sciences Inc

Market Cap

$544M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$5.13+$0.16 (+3.22%)

Jun 5, 2026

52W High $5.9952W Low $2.07

Company Details

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurr...

CEO

—

IPO Date

Oct 13, 1995

Website

www.achievelifesciences.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$52M

EPS (Diluted)

Free Cash Flow

-$45M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 12, 2026

FY 2025

Mar 24, 2026

Q4 2025

Mar 24, 2026

$0-100.0%

Q3 2025

Nov 6, 2025

Q2 2025

Aug 7, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee